US2010204294A1PendingUtilityA1
Methods For Assessing, Improving, Or Maintaining Urogenital Health in Postmenopausal Woman
Est. expiryOct 16, 2020(expired)· nominal 20-yr term from priority
A61P 5/30A61P 43/00A61K 31/4453A61K 31/40A61K 31/55A61K 31/407A61P 13/02A61P 15/02A61P 13/00A61K 31/4025A61K 31/403A61K 31/138A61K 31/00A61K 31/453A61P 1/00A61K 31/439A61P 15/00A61K 31/4535A61K 31/445A61K 31/192A61K 31/517
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to methods and kits useful for improving or maintaining urogenital health using an estrogen agonist/antagonist. The methods of treatment are effective for improving or maintaining urogenital health while substantially reducing the concomitant liability of adverse effects associated with estrogen administration. This invention also relates to methods of assessing vaginal health.
Claims
exact text as granted — not AI-modified1 .- 10 . (canceled)
11 . A method of treating a urinary tract infection, a vaginal yeast or bacterial infection, vaginitis or undesired vaginal spasms by administering to a patient in need thereof a therapeutically effective amount of a compound of formula (IA)
wherein G is
R 4 is H, OH, F, or Cl; and B and E are independently selected from CH and N or an optical isomer thereof; or a pharmaceutically acceptable salt thereof.
12 . The method of claim 11 wherein the compound is (−)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydro-naphthalene-2-ol or a pharmaceutically acceptable salt thereof.
13 . The method of claim 12 wherein the compound is in the form of a D-tartrate salt.
14 .- 105 . (canceled)
106 . The method of claim 12 wherein the patient is post-menopausal.Join the waitlist — get patent alerts
Track US2010204294A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.